Global Antibody Drug Conjugate Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antibody Drug Conjugate Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antibody Drug Conjugate by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antibody Drug Conjugate by Country/Region, 2017, 2022 & 2028

2.2 Antibody Drug Conjugate Segment by Type

2.2.1 Adcetris

2.2.2 Kadcyl

2.2.3 Other

2.3 Antibody Drug Conjugate Sales by Type

2.3.1 Global Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

2.3.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antibody Drug Conjugate Sale Price by Type (2017-2022)

2.4 Antibody Drug Conjugate Segment by Application

2.4.1 Hospital

2.4.2 Pharmaceutical Company

2.4.3 Research Institutions

2.5 Antibody Drug Conjugate Sales by Application

2.5.1 Global Antibody Drug Conjugate Sale Market Share by Application (2017-2022)

2.5.2 Global Antibody Drug Conjugate Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antibody Drug Conjugate Sale Price by Application (2017-2022)

3 Global Antibody Drug Conjugate by Company

3.1 Global Antibody Drug Conjugate Breakdown Data by Company

3.1.1 Global Antibody Drug Conjugate Annual Sales by Company (2020-2022)

3.1.2 Global Antibody Drug Conjugate Sales Market Share by Company (2020-2022)

3.2 Global Antibody Drug Conjugate Annual Revenue by Company (2020-2022)

3.2.1 Global Antibody Drug Conjugate Revenue by Company (2020-2022)

3.2.2 Global Antibody Drug Conjugate Revenue Market Share by Company (2020-2022)

3.3 Global Antibody Drug Conjugate Sale Price by Company

3.4 Key Manufacturers Antibody Drug Conjugate Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antibody Drug Conjugate Product Location Distribution

3.4.2 Players Antibody Drug Conjugate Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antibody Drug Conjugate by Geographic Region

4.1 World Historic Antibody Drug Conjugate Market Size by Geographic Region (2017-2022)

4.1.1 Global Antibody Drug Conjugate Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antibody Drug Conjugate Annual Revenue by Geographic Region

4.2 World Historic Antibody Drug Conjugate Market Size by Country/Region (2017-2022)

4.2.1 Global Antibody Drug Conjugate Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antibody Drug Conjugate Annual Revenue by Country/Region

4.3 Americas Antibody Drug Conjugate Sales Growth

4.4 APAC Antibody Drug Conjugate Sales Growth

4.5 Europe Antibody Drug Conjugate Sales Growth

4.6 Middle East & Africa Antibody Drug Conjugate Sales Growth

5 Americas

5.1 Americas Antibody Drug Conjugate Sales by Country

5.1.1 Americas Antibody Drug Conjugate Sales by Country (2017-2022)

5.1.2 Americas Antibody Drug Conjugate Revenue by Country (2017-2022)

5.2 Americas Antibody Drug Conjugate Sales by Type

5.3 Americas Antibody Drug Conjugate Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antibody Drug Conjugate Sales by Region

6.1.1 APAC Antibody Drug Conjugate Sales by Region (2017-2022)

6.1.2 APAC Antibody Drug Conjugate Revenue by Region (2017-2022)

6.2 APAC Antibody Drug Conjugate Sales by Type

6.3 APAC Antibody Drug Conjugate Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antibody Drug Conjugate by Country

7.1.1 Europe Antibody Drug Conjugate Sales by Country (2017-2022)

7.1.2 Europe Antibody Drug Conjugate Revenue by Country (2017-2022)

7.2 Europe Antibody Drug Conjugate Sales by Type

7.3 Europe Antibody Drug Conjugate Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antibody Drug Conjugate by Country

8.1.1 Middle East & Africa Antibody Drug Conjugate Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antibody Drug Conjugate Revenue by Country (2017-2022)

8.2 Middle East & Africa Antibody Drug Conjugate Sales by Type

8.3 Middle East & Africa Antibody Drug Conjugate Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antibody Drug Conjugate

10.3 Manufacturing Process Analysis of Antibody Drug Conjugate

10.4 Industry Chain Structure of Antibody Drug Conjugate

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antibody Drug Conjugate Distributors

11.3 Antibody Drug Conjugate Customer

12 World Forecast Review for Antibody Drug Conjugate by Geographic Region

12.1 Global Antibody Drug Conjugate Market Size Forecast by Region

12.1.1 Global Antibody Drug Conjugate Forecast by Region (2023-2028)

12.1.2 Global Antibody Drug Conjugate Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antibody Drug Conjugate Forecast by Type

12.7 Global Antibody Drug Conjugate Forecast by Application

13 Key Players Analysis

13.1 Seattle Genetics/Takeda

13.1.1 Seattle Genetics/Takeda Company Information

13.1.2 Seattle Genetics/Takeda Antibody Drug Conjugate Product Offered

13.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Seattle Genetics/Takeda Main Business Overview

13.1.5 Seattle Genetics/Takeda Latest Developments

13.2 Roche

13.2.1 Roche Company Information

13.2.2 Roche Antibody Drug Conjugate Product Offered

13.2.3 Roche Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Roche Main Business Overview

13.2.5 Roche Latest Developments

13.3 ImmunoGen

13.3.1 ImmunoGen Company Information

13.3.2 ImmunoGen Antibody Drug Conjugate Product Offered

13.3.3 ImmunoGen Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 ImmunoGen Main Business Overview

13.3.5 ImmunoGen Latest Developments

13.4 Immunomedics

13.4.1 Immunomedics Company Information

13.4.2 Immunomedics Antibody Drug Conjugate Product Offered

13.4.3 Immunomedics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Immunomedics Main Business Overview

13.4.5 Immunomedics Latest Developments

13.5 Pfizer

13.5.1 Pfizer Company Information

13.5.2 Pfizer Antibody Drug Conjugate Product Offered

13.5.3 Pfizer Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer Main Business Overview

13.5.5 Pfizer Latest Developments

13.6 Celldex Therapeutics

13.6.1 Celldex Therapeutics Company Information

13.6.2 Celldex Therapeutics Antibody Drug Conjugate Product Offered

13.6.3 Celldex Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Celldex Therapeutics Main Business Overview

13.6.5 Celldex Therapeutics Latest Developments

13.7 Millennium Pharmaceuticals

13.7.1 Millennium Pharmaceuticals Company Information

13.7.2 Millennium Pharmaceuticals Antibody Drug Conjugate Product Offered

13.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Millennium Pharmaceuticals Main Business Overview

13.7.5 Millennium Pharmaceuticals Latest Developments

13.8 Bayer HealthCare

13.8.1 Bayer HealthCare Company Information

13.8.2 Bayer HealthCare Antibody Drug Conjugate Product Offered

13.8.3 Bayer HealthCare Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bayer HealthCare Main Business Overview

13.8.5 Bayer HealthCare Latest Developments

13.9 Mersana Therapeutics

13.9.1 Mersana Therapeutics Company Information

13.9.2 Mersana Therapeutics Antibody Drug Conjugate Product Offered

13.9.3 Mersana Therapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Mersana Therapeutics Main Business Overview

13.9.5 Mersana Therapeutics Latest Developments

13.10 Heidelberg Pharma

13.10.1 Heidelberg Pharma Company Information

13.10.2 Heidelberg Pharma Antibody Drug Conjugate Product Offered

13.10.3 Heidelberg Pharma Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Heidelberg Pharma Main Business Overview

13.10.5 Heidelberg Pharma Latest Developments

13.11 Oxford BioTherapeutics

13.11.1 Oxford BioTherapeutics Company Information

13.11.2 Oxford BioTherapeutics Antibody Drug Conjugate Product Offered

13.11.3 Oxford BioTherapeutics Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Oxford BioTherapeutics Main Business Overview

13.11.5 Oxford BioTherapeutics Latest Developments

13.12 Takeda Pharmaceutical Company Limited

13.12.1 Takeda Pharmaceutical Company Limited Company Information

13.12.2 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Offered

13.12.3 Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.12.5 Takeda Pharmaceutical Company Limited Latest Developments

14 Research Findings and Conclusion

Table 1. Antibody Drug Conjugate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antibody Drug Conjugate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Adcetris

Table 4. Major Players of Kadcyl

Table 5. Major Players of Other

Table 6. Global Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)

Table 7. Global Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

Table 8. Global Antibody Drug Conjugate Revenue by Type (2017-2022) & ($ million)

Table 9. Global Antibody Drug Conjugate Revenue Market Share by Type (2017-2022)

Table 10. Global Antibody Drug Conjugate Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)

Table 12. Global Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Table 13. Global Antibody Drug Conjugate Revenue by Application (2017-2022)

Table 14. Global Antibody Drug Conjugate Revenue Market Share by Application (2017-2022)

Table 15. Global Antibody Drug Conjugate Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Antibody Drug Conjugate Sales by Company (2020-2022) & (K Units)

Table 17. Global Antibody Drug Conjugate Sales Market Share by Company (2020-2022)

Table 18. Global Antibody Drug Conjugate Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Antibody Drug Conjugate Revenue Market Share by Company (2020-2022)

Table 20. Global Antibody Drug Conjugate Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Antibody Drug Conjugate Producing Area Distribution and Sales Area

Table 22. Players Antibody Drug Conjugate Products Offered

Table 23. Antibody Drug Conjugate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Antibody Drug Conjugate Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Antibody Drug Conjugate Sales Market Share Geographic Region (2017-2022)

Table 28. Global Antibody Drug Conjugate Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Antibody Drug Conjugate Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Antibody Drug Conjugate Sales Market Share by Country/Region (2017-2022)

Table 32. Global Antibody Drug Conjugate Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Antibody Drug Conjugate Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)

Table 35. Americas Antibody Drug Conjugate Sales Market Share by Country (2017-2022)

Table 36. Americas Antibody Drug Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Antibody Drug Conjugate Revenue Market Share by Country (2017-2022)

Table 38. Americas Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)

Table 39. Americas Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

Table 40. Americas Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)

Table 41. Americas Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Table 42. APAC Antibody Drug Conjugate Sales by Region (2017-2022) & (K Units)

Table 43. APAC Antibody Drug Conjugate Sales Market Share by Region (2017-2022)

Table 44. APAC Antibody Drug Conjugate Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Antibody Drug Conjugate Revenue Market Share by Region (2017-2022)

Table 46. APAC Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)

Table 47. APAC Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

Table 48. APAC Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)

Table 49. APAC Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Table 50. Europe Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)

Table 51. Europe Antibody Drug Conjugate Sales Market Share by Country (2017-2022)

Table 52. Europe Antibody Drug Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Antibody Drug Conjugate Revenue Market Share by Country (2017-2022)

Table 54. Europe Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)

Table 55. Europe Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

Table 56. Europe Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)

Table 57. Europe Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Antibody Drug Conjugate Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Antibody Drug Conjugate Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Antibody Drug Conjugate Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Antibody Drug Conjugate Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Antibody Drug Conjugate

Table 67. Key Market Challenges & Risks of Antibody Drug Conjugate

Table 68. Key Industry Trends of Antibody Drug Conjugate

Table 69. Antibody Drug Conjugate Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Antibody Drug Conjugate Distributors List

Table 72. Antibody Drug Conjugate Customer List

Table 73. Global Antibody Drug Conjugate Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Antibody Drug Conjugate Sales Market Forecast by Region

Table 75. Global Antibody Drug Conjugate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Antibody Drug Conjugate Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Antibody Drug Conjugate Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Antibody Drug Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Antibody Drug Conjugate Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Antibody Drug Conjugate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Antibody Drug Conjugate Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Antibody Drug Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Antibody Drug Conjugate Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Antibody Drug Conjugate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Antibody Drug Conjugate Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Antibody Drug Conjugate Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Antibody Drug Conjugate Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Antibody Drug Conjugate Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Antibody Drug Conjugate Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Antibody Drug Conjugate Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Antibody Drug Conjugate Revenue Market Share Forecast by Application (2023-2028)

Table 93. Seattle Genetics/Takeda Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 94. Seattle Genetics/Takeda Antibody Drug Conjugate Product Offered

Table 95. Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Seattle Genetics/Takeda Main Business

Table 97. Seattle Genetics/Takeda Latest Developments

Table 98. Roche Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 99. Roche Antibody Drug Conjugate Product Offered

Table 100. Roche Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Roche Main Business

Table 102. Roche Latest Developments

Table 103. ImmunoGen Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 104. ImmunoGen Antibody Drug Conjugate Product Offered

Table 105. ImmunoGen Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. ImmunoGen Main Business

Table 107. ImmunoGen Latest Developments

Table 108. Immunomedics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 109. Immunomedics Antibody Drug Conjugate Product Offered

Table 110. Immunomedics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Immunomedics Main Business

Table 112. Immunomedics Latest Developments

Table 113. Pfizer Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 114. Pfizer Antibody Drug Conjugate Product Offered

Table 115. Pfizer Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Pfizer Main Business

Table 117. Pfizer Latest Developments

Table 118. Celldex Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 119. Celldex Therapeutics Antibody Drug Conjugate Product Offered

Table 120. Celldex Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Celldex Therapeutics Main Business

Table 122. Celldex Therapeutics Latest Developments

Table 123. Millennium Pharmaceuticals Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 124. Millennium Pharmaceuticals Antibody Drug Conjugate Product Offered

Table 125. Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Millennium Pharmaceuticals Main Business

Table 127. Millennium Pharmaceuticals Latest Developments

Table 128. Bayer HealthCare Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 129. Bayer HealthCare Antibody Drug Conjugate Product Offered

Table 130. Bayer HealthCare Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Bayer HealthCare Main Business

Table 132. Bayer HealthCare Latest Developments

Table 133. Mersana Therapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 134. Mersana Therapeutics Antibody Drug Conjugate Product Offered

Table 135. Mersana Therapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Mersana Therapeutics Main Business

Table 137. Mersana Therapeutics Latest Developments

Table 138. Heidelberg Pharma Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 139. Heidelberg Pharma Antibody Drug Conjugate Product Offered

Table 140. Heidelberg Pharma Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. Heidelberg Pharma Main Business

Table 142. Heidelberg Pharma Latest Developments

Table 143. Oxford BioTherapeutics Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 144. Oxford BioTherapeutics Antibody Drug Conjugate Product Offered

Table 145. Oxford BioTherapeutics Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Oxford BioTherapeutics Main Business

Table 147. Oxford BioTherapeutics Latest Developments

Table 148. Takeda Pharmaceutical Company Limited Basic Information, Antibody Drug Conjugate Manufacturing Base, Sales Area and Its Competitors

Table 149. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Product Offered

Table 150. Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Takeda Pharmaceutical Company Limited Main Business

Table 152. Takeda Pharmaceutical Company Limited Latest Developments

List of Figures

Figure 1. Picture of Antibody Drug Conjugate

Figure 2. Antibody Drug Conjugate Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antibody Drug Conjugate Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Antibody Drug Conjugate Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antibody Drug Conjugate Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Adcetris

Figure 10. Product Picture of Kadcyl

Figure 11. Product Picture of Other

Figure 12. Global Antibody Drug Conjugate Sales Market Share by Type in 2021

Figure 13. Global Antibody Drug Conjugate Revenue Market Share by Type (2017-2022)

Figure 14. Antibody Drug Conjugate Consumed in Hospital

Figure 15. Global Antibody Drug Conjugate Market: Hospital (2017-2022) & (K Units)

Figure 16. Antibody Drug Conjugate Consumed in Pharmaceutical Company

Figure 17. Global Antibody Drug Conjugate Market: Pharmaceutical Company (2017-2022) & (K Units)

Figure 18. Antibody Drug Conjugate Consumed in Research Institutions

Figure 19. Global Antibody Drug Conjugate Market: Research Institutions (2017-2022) & (K Units)

Figure 20. Global Antibody Drug Conjugate Sales Market Share by Application (2017-2022)

Figure 21. Global Antibody Drug Conjugate Revenue Market Share by Application in 2021

Figure 22. Antibody Drug Conjugate Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Antibody Drug Conjugate Revenue Market Share by Company in 2021

Figure 24. Global Antibody Drug Conjugate Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Antibody Drug Conjugate Revenue Market Share by Geographic Region in 2021

Figure 26. Global Antibody Drug Conjugate Sales Market Share by Region (2017-2022)

Figure 27. Global Antibody Drug Conjugate Revenue Market Share by Country/Region in 2021

Figure 28. Americas Antibody Drug Conjugate Sales 2017-2022 (K Units)

Figure 29. Americas Antibody Drug Conjugate Revenue 2017-2022 ($ Millions)

Figure 30. APAC Antibody Drug Conjugate Sales 2017-2022 (K Units)

Figure 31. APAC Antibody Drug Conjugate Revenue 2017-2022 ($ Millions)

Figure 32. Europe Antibody Drug Conjugate Sales 2017-2022 (K Units)

Figure 33. Europe Antibody Drug Conjugate Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Antibody Drug Conjugate Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Antibody Drug Conjugate Revenue 2017-2022 ($ Millions)

Figure 36. Americas Antibody Drug Conjugate Sales Market Share by Country in 2021

Figure 37. Americas Antibody Drug Conjugate Revenue Market Share by Country in 2021

Figure 38. United States Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Antibody Drug Conjugate Sales Market Share by Region in 2021

Figure 43. APAC Antibody Drug Conjugate Revenue Market Share by Regions in 2021

Figure 44. China Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Antibody Drug Conjugate Sales Market Share by Country in 2021

Figure 51. Europe Antibody Drug Conjugate Revenue Market Share by Country in 2021

Figure 52. Germany Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Antibody Drug Conjugate Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Antibody Drug Conjugate Revenue Market Share by Country in 2021

Figure 59. Egypt Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Antibody Drug Conjugate Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Antibody Drug Conjugate in 2021

Figure 65. Manufacturing Process Analysis of Antibody Drug Conjugate

Figure 66. Industry Chain Structure of Antibody Drug Conjugate

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles